Cancer of Unknown Primary Site Completed Phase 1 Trials for Geptanolimab (DB16417)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0089665 (Cancer of Unknown Primary Site) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03053466 | APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors | Treatment |